Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations

Purpose To assess the safety and effectiveness of polidocanol sclerotherapy combined with transarterial embolization using a liquid adhesive agent ( n -butyl cyanoacrylate, NBCA) for treatment of extracranial arteriovenous malformations (AVMs). Materials and Methods Twenty-three patients with sympto...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular and interventional radiology 2018-06, Vol.41 (6), p.856-866
Main Authors: Kitagawa, Akira, Yamamoto, Takahiro, Matsunaga, Nozomu, Yamaji, Mayako, Ikeda, Shuji, Izumi, Yuichiro, Hagihara, Makiyo, Ota, Toyohiro, Ishiguchi, Tsuneo
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Angiography
Arteriovenous Malformations - diagnostic imaging
Arteriovenous Malformations - therapy
Carbon dioxide
Cardiology
Child
Child, Preschool
Clinical Investigation
Complications
Embolization
Embolization, Therapeutic - methods
Enbucrilate - therapeutic use
Female
Head and neck
Humans
Imaging
Male
Medicine
Medicine & Public Health
Middle Aged
Nuclear Medicine
Patients
Polidocanol
Polyethylene Glycols - therapeutic use
Radiology
Remission
Retrospective Studies
Sclerosing Solutions - therapeutic use
Sclerotherapy
Sclerotherapy - methods
Skin
Thromboembolism
Thrombosis
Treatment Outcome
Ultrasound
Young Adult
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose To assess the safety and effectiveness of polidocanol sclerotherapy combined with transarterial embolization using a liquid adhesive agent ( n -butyl cyanoacrylate, NBCA) for treatment of extracranial arteriovenous malformations (AVMs). Materials and Methods Twenty-three patients with symptomatic AVMs in the head and neck (6), upper (7) and lower extremity (10) with a mean age of 42 years (range 4–74) treated with polidocanol sclerotherapy were retrospectively assessed. AVMs were classified according to the angiographic morphology of the nidus. There were 2 type I, 6 type II, 6 type IIIa and 9 type IIIb. Arterial embolization using NBCA was performed to reduce arterial flow before sclerotherapy. Polidocanol mixed with contrast material or carbon dioxide was delivered by percutaneous direct puncture. Results Treatment was successfully performed in all patients. In the mean follow-up period of 38 months, symptoms resolved or improved in 20/23 patients (87.0%). AVMs were devascularized 100% in 2 patients, 76–99% in 13, 50–75% in 7 and
ISSN:0174-1551
1432-086X
DOI:10.1007/s00270-017-1855-2